Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway
Ning Zhu, Xiaohong Chen, Junjun Zhao, Lijuan Fang, Yingmin Yao, Feifei Zhou, Tao Liang, Qiuran Xu · Journal of Cancer · 2022
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2022
Abstract
The hypoxic tumor microenvironment, a fundamental feature of solid tumors, drives hepatocellular carcinoma (HCC) progression through regulating the transcriptional activities of protein-coding and noncoding genes.However, long noncoding RNA (lncRNA)-mediated HCC progression in hypoxic microenvironment remains largely unknown yet.In this study, we found that LINC00674 was upregulated under hypoxic conditions in a HIF-1-dependent manner, and the occupancy of HIF-1 to HRE of LINC00674 gene promoter was essential for its transcription.In addition, LINC00674 level was increased in HCC cell lines and tissues.Clinically, statistical analysis showed that LINC00674 expression was significantly associated with tumor size, venous infiltration, tumor stage and poor prognosis of HCC.Functionally, loss-of-function assays revealed that LINC00674 knockdown inhibited the migration, proliferation and invasion of HCC cells.Furthermore, LINC00674 silencing prominently repressed the mTOR signaling pathway.LINC00674 overexpression-enhanced HCC cell proliferation, migration and invasion were markedly abolished by an mTOR inhibitor rapamycin.NADPH oxidase 1 (NOX1) was positively regulated by LINC00674 in HCC cells.NOX1 knockdown markedly reversed LINC00674-upregulated the p-mTOR level and HCC cells' malignant behaviors.Finally, we found that LINC00674 knockdown attenuated the growth of HCC cells in vivo.Our finding demonstrated that LINC00674 was a new HIF-1 target gene, and hypoxia-induced LINC00674 exerted a pro-proliferative and pro-metastatic role in HCC, possibly by activating the NOX1/mTOR signaling pathway.This study suggested LINC00674 as a promising therapeutic target for HCC.
Open the resolved locator · 10.7150/jca.76458
Metadata licence: OpenAlex metadata (CC0)